MIRAPEX ER Trademark

Trademark Overview

On Tuesday, November 4, 2008, a trademark application was filed for MIRAPEX ER with the United States Patent and Trademark Office. The USPTO has given the MIRAPEX ER trademark a serial number of 77606808. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 7, 2017. This trademark is owned by Boehringer Ingelheim Pharma GmbH & Co. KG. The MIRAPEX ER trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of central nervous system
mirapex er

General Information

Serial Number77606808
Word MarkMIRAPEX ER
Filing DateTuesday, November 4, 2008
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 7, 2017
Registration Number3838544
Registration DateTuesday, August 24, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 24, 2009

Trademark Statements

Disclaimer with Predetermined Text"ER"
Goods and ServicesPharmaceutical preparations for the treatment of central nervous system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 7, 2017
Primary Code005
First Use Anywhere DateWednesday, February 24, 2010
First Use In Commerce DateWednesday, February 24, 2010

Trademark Owner History

Party NameBoehringer Ingelheim Pharma GmbH & Co. KG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIngelheim am Rhein 55216
DE
Party NameBoehringer Ingelheim Pharma GmbH & Co. KG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIngelheim am Rhein 55216
DE
Party NameBoehringer Ingelheim Pharma GmbH & Co. KG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIngelheim am Rhein 55216
DE

Trademark Events

Event DateEvent Description
Friday, April 7, 2017CANCELLED SEC. 8 (6-YR)
Tuesday, August 24, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, July 20, 2010NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
Monday, July 19, 2010LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, July 16, 2010ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, July 16, 2010AMENDMENT FROM APPLICANT ENTERED
Friday, July 16, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 14, 2010PAPER RECEIVED
Tuesday, May 18, 2010NON-FINAL ACTION MAILED
Monday, May 17, 2010SU - NON-FINAL ACTION - WRITTEN
Tuesday, April 20, 2010STATEMENT OF USE PROCESSING COMPLETE
Monday, March 22, 2010USE AMENDMENT FILED
Tuesday, April 20, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 22, 2010PAPER RECEIVED
Tuesday, September 22, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 13, 2009CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Wednesday, August 12, 2009ASSIGNED TO PETITION STAFF
Friday, August 7, 2009EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Monday, June 1, 2009PAPER RECEIVED
Thursday, April 23, 2009EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, March 24, 2009PUBLISHED FOR OPPOSITION
Wednesday, March 4, 2009NOTICE OF PUBLICATION
Thursday, February 19, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 18, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 18, 2009AMENDMENT FROM APPLICANT ENTERED
Wednesday, February 18, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 18, 2009ASSIGNED TO LIE
Tuesday, February 17, 2009PAPER RECEIVED
Monday, January 12, 2009NON-FINAL ACTION MAILED
Friday, January 9, 2009NON-FINAL ACTION WRITTEN
Tuesday, December 30, 2008ASSIGNED TO EXAMINER
Friday, November 7, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

mirapex nervous system central treatment preparations pharmaceutical